Evidence that fibroblast growth factor 5 is a major muscle-derived survival factor for cultured spinal motoneurons by Hughes, Richard A. et al.
Neuron. Vol. 10. 369-377. March. 1993. Copyright © 1993 by Cell Press 
Evidence That Fibroblast Growth Factor 5 
Is a Major Muscle-Derived Survival Factor 
for Cultured Spinal Motoneurons 
Richard A. Hughes,· Michael Sendtner," 
Mitchell Goldfarb, t Dan Lindholm,· 
and Hans Thoenen" 
"Department of Neurochemistry 
Max-Planck-Institute for Psychiatry 
8033 Planegg-Martinsried 
Germany 
tDepartment of Biochemistry 
and Molecular Biophysics 
College of Physicians and Surgeons 
Columbia University 
New York, New York 10032 
Summary 
We examined the potential role of fibroblast growth 
factor 5 (FGF-5) as a target-derived trophic factor for 
spinal motoneurons. Northern analysis of total RNA 
from rat skeletal muscle revealed an FGF-5 mRNA 
transcript both during the period of embryonic moto-
neuron death and in the adult. Recombinant human 
FGF-5 supported the survival of highly enriched cultures 
of embryonic chick motoneurons. Significant propor-
tions of the motoneuron survival activity of rat skeletal 
muscle extracts could be immunoprecipitated using an 
antiserum to FGF-5. The immunoprecipitable activity 
was present in soluble and matrix-bound forms in em-
bryonic muscle, but bound exclusively to the extra-
cellular matrix in adult muscle. These results, along with 
the secretory nature of FGF-5, suggest that FGF-5 may 
act as a target-derived trophic factor for motoneurons. 
Introduction 
During the course of embryonic development, many 
neuronal populations undergo a period of naturally 
occurring cell death. In the vertebrate, the survival of 
neurons during this period has been demonstrated in 
several instances to be dependent upon access of the 
developing neurons to specific trophic factors sup-
plied by target tissues (for review, see Oppenheim, 
1991). For example, nerve growth factor (NGF) is 
known to be produced in limiting amounts in the tar-
get tissues of peripheral sympathetic and sensory 
neurons, and considerable evidence has been accu-
mulated demonstrating that NGF supports the survival 
of these cells during critical stages of development 
(for review, see Barde, 1989). Similarly, motoneurons 
have been shown to rely upon their target during the 
embryonic period of naturally occurring cell death 
(Hamburger, 1958; Hollyday and Hamburger, 1976). 
In addition, a number of groups have described the 
ability of extracts of skeletal muscle, the target of mo-
toneurons, to promote the survival of motoneurons 
in culture (Bennett et al., 1980; Schnaar and Schaffner, 
1981; Calof and Reichardt, 1984; Kaufman et al., 1985; 
Flanigan et al., 1985; Smith et al., 1985; Dohrmann et 
al., 1986; O'Brien and Fischbach, 1986; Martinou et al., 
1989; Arakawa et al., 1990; Bloch-Gallego et al., 1991; 
Jeong et al., 1991). However, attempts to determine 
the molecular nature of the factor(s) involved in regu-
lating motoneuron survival during development have 
been largely unfruitful. 
We have previously demonstrated that several neu-
rotrophic and growth factors support the survival of 
spinal motoneurons in highly enriched cultures taken 
horn embryonic day 6 (E6) chick (Arakawa et al., 1990). 
The best of these, ciliary neurotrophic factor (CNTF) 
and basic fibroblast growth factor (bFGF), support the 
survival of approximately 60% and 50%, respectively, 
of the initially plated motoneurons after 3 days in 
culture. In combination, CNTF and bFGF give 100% 
motoneuron survival under the in vitro conditions 
employed. Furthermore, exogenously applied recom-
binant CNTF is able to prevent the otherwise exten-
sive motoneuron degeneration seen after lesion of 
the facial nerve of the newborn rat (Sendtner et al., 
1990) as well as rescue a significant number of spinal 
motoneurons that would otherwise undergo naturally 
occurring cell death in the embryonic chick (Oppen-
heim et al., 1991). However, neither CNTF nor bFGF is 
likely to be responsible for the physiological regula-
tion of embryonic neuronal survival, since both CNTF 
and bFGF are apparently cytosolic molecules (Ab ra-
ham et al., 1986; Lin et al., 1989; Stockli et al., 1989) and 
CNTF mRNA cannot be detected in skeletal muscle 
during the period of embryonic motoneuron death in 
the rat (Stockli et al., 1991). 
To meet the requirements expected of a neuro-
trophiC factor capable of regulating motoneuron sur-
vival during the embryonic period of cell death, a 
putative candidate molecule should support moto-
neuron survival and be appropriately expressed in 
target tissues. We have examined a member of the 
FGF family, FGF-5, for its ability to fulfill these criteria. 
FGF-5 was originally described as the product of a 
human oncogene (Zhan et al., 1987) and upon cloning 
was found to belong to the FGF family (Zhan et al., 
1988). FGF-5 consists of 268 amino acids and appears 
to be moderately well conserved across mammals; 
the murine homolog shows 84% overall amino acid 
identity with the human form (Hebert et al., 1990). 
Unlike the prototypical FGFs, acidic FGF (aFGF) and 
bFGF. FGF-5 contains a hydrophobic N-terminal 
leader sequence typical of a secreted protein (Zhan et 
al., 1988) and is released into the medium of trans-
formed NIH 3T3 cells (Bates et al., 1991). mRNA for 
FGF-5 can be found prior to gastrulation in mouse 
embryos, suggesting that this factor may have an im-
portant function during very early stages of embry-
onic development (Hebert et al., 1991; Haub and Gold-
farb, 1991). We demonstrate here that recombinant 
human FGF-5 is able to support the survival of chick 
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spinal motoneurons in culture and that both FGF-5 50 
mRNA and immunoprecipitable activity are present 
in embryonic rat skeletal muscle during the period of 
naturally occurring motoneuron death as well as in 
adult muscle. The data indicate that FGF-5 b a major 
survival factor present in skeletal muscle for cultured 
spinal motoneurons and, taken together with the se-
cretory nature of FGF-5, are consistent with a potential 
role for this protein in the maintenance of motoneu-
ron survival during development and adulthood. 
Results 
The mRNA for FGF-5 Is Expressed in Rat Skeletal 
Muscle during Embryonic Development and in 
the Adult 
To determine whether FGF-5 mRNA is expressed in 
the target tissue of motoneurons either during embry-
onicdevelopment or in adulthood, we performed 
Northern blot analysis of total RNA obtained from 
hindlimb skeletal muscle of embryonic (E15 and El7), 
newborn, and adult rats. Following high stringency 
washing, a cRNA probe from mouse FGF-5 was found 
to hybridize specifically to a band migrating margin-
ally faster than the 18S band (approximately 1.7 kb) 
in rat skeletal muscle RNA at all time points studied 
(Figure la). The FGF-5-specific transcript observed in 
muscle is similar in size to the major FGF-5 transcript 
seen in Northern blots of polyadenylated RNA ob-
tained from cultured human fibroblasts (Werner et 
aI., 1991). The probe also hybridizes to a band of identi-
cal size in adult rat hippocampus (Figure lb), a known 
site of FGF-5 expression in the mouse (Haub et aI., 
1990). 
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Figure 1. Northern Blots Hybridized with a 500 bp cRNA Probe 
to FGF-5 
(a) Total RNA (16 J.lg) from embryonic (E15 and El7), newborn 
(NB), and adult (A) rat skeletal muscle. Blot were exposed for 7 
days. 
(b) Comparison of size of FGF-5 transcript in 5 J.lg of total RNA 
obtained from E15 rat skeletal muscle (E15) and adult rat hippo-
campus (H). Blots were exposed for 3 days. The positions of the 
FGF-5-specific message and of the 185 and 285 ribosomal RNA 
bands are indicated by arrows. 
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Figure 2. Effects of Increasing Concentration of Recombinant 
Human FGF-5 on Survival of Cultured E6 Chick Motoneurons in 
the Absence and Presence of Heparin 
Results are means ± 1 standard deviation from a minimum of 
four cultures irom at least two independent experiments. 
Open circles. no added heparin; closed circles. 500 ng/ml 
heparin. 
FGF-5 Supports the Survival of E6 Chick Spinal 
Motoneurons in Culture 
The ability of recombinant human FGF-5 to support 
the survival of E6 chick motoneurons in vitro was de-
termined in the absence and presence of heparin (Fig-
ure 2). Alone, FGF-5 supports the survival of a maxi-
mum of 27% of the initially plated motoneurons at a 
concentration of 10 ng/ml after 72 hr in culture. In the 
presence of heparin sulphate (500 ng/ml), the survival 
effect of FGF-5 is increased significantly, such that 45% 
of plated motoneurons are supported at a concentra-
tion of 100 ng/ml. Motoneurons cultured in the pres-
ence of the same concentration of heparin alone did 
not exhibit Significantly better survival behavior than 
control cultures (9% survival after 3 days). The concen-
tration of FGF-5 required to give half-maximal survival 
of motoneurons is 800 pg/ml. Thus, in cultures of E6 
chick spinal motoneurons, FGF-5 is less effective in 
promoting neuronal survival than either bFGF or 
CNTF (maximally 50% and 61 % survival, respectively, 
after 3 days in culture), but significantly better than 
other heparin-dependent members of the FGF family 
tested, such as aFGF and hst/K-FGF (maximally 36% 
and 32% survival, respectively, after 3 days in culture; 
Figure 3). Furthermore, combination of FGF-5 with ei-
ther CNTF or bFGF at supramaximal concentrations 
in the presence of heparin (500nglml) gave an additive 
effect on motoneuron survival, such that FGF-5 and 
CNTF or FGF-5 and bFGF supported approximately 
74% and 80%, respectively, of the originally plated 
motoneurons after 3 days in culture (Figure 3). Simi-
larly to CNTF and bFGF, FGF-5 supported the survival 
of cultured E8 chick ciliary ganglion neurons (data not 
shown). 
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Figure 3. Comparison of Maximum Motoneuron Survival Activity 
and Synergism of FGF-5 with CNTF and Other Members of the 
FGF Family 
Factors were added to cultures in concentrations previously de-
termined as exhibiting maximal survival effects: FGF-S, aFGF, and 
hstIK-FGF at lOO nglml; bFGF at 20 nglml; CNTF at 1 ng/ml. Results 
are means from six determinations from three independent ex-
periments. Error bars represent 1 SEM. Statistical significance 
was established with Student's t test: • Survival significantly dif-
ferent from cultures containing bFGF alone, P < 0.00005 .•• Sur-
vival significantly different from CNTF alone, P < 0.005. 
A Significant Proportion of the Survival Activity of 
Extracts of Embryonic Skeletal Muscle Can Be 
Precipitated with an Anti-FGF-5 Peptide Antiserum 
To investigate the contribution, if any, of FGF-S to the 
motoneuron survival activity of embryonic and adult 
rat skeletal muscle extracts, we performed immuno-
precipitation experiments with an antiserum to FGF-S. 
The antiserum was raised in rabbits against a synthetic 
peptide representing a sequence from near the C-ter-
minus of human FGF-5. The sequence was judged by 
hydropathy analysis (Hoppand Woods, 1981; Kyte and 
Doolittle, 1982) to be relatively hydrophilic and there-
fore likely to be exposed on the surface of intact FGF-S. 
Furthermore, the peptide spans a region of the C-ter-
minal "tail" of FGF-5, which, although well conserved 
between species, is not present in the other known 
members of the FGF family; this fact reduces the likeli-
hood that the resultant antiserum would cross-react 
with other FGFs. Although the antiserum raised 
against this peptide did not recognize recombinant 
human FGF-5 on immunoblots (data not shown), it 
was possible to precipitate the motoneuron survival 
activity of recombinant human FGF-5 almost entirely 
using the antiserum (Figure 4),.consistent with an abil-
ity of this antiserum to recognize native FGF-5 in solu-
tion. In contrast, the antiserum was unable to immu-
noprecipitate the motoneuron survival activity of 
either any other member of the FGF family tested 
(aFGF, bFGF, and hst/K-FGF) or CNTF. 
Figure 5 shows the motoneuron survival activity of 
an extract of phosphate-buffered saline (PBS)-soluble 
components of E17 rat skeletal muscle before (column 
B) and after (column C) the addition of anti-FGF-S anti-
serum bound to protein G-Sepharose. Following cen-
trifugation of the antiserum-Sepharose complex, the 
survival activity of the soluble embryonic muscle ex-
tract on E6 chick spinal motoneurons at the maximum 
protein concentration tested (250 I!g/ml) was reduced 
from 60% to 36% after 3 days in culture. This repre-
sents a 47% reduction in survival activity, given the 
background survival of 9% in control cultures (Figure 
S, column A). The result suggests that a significant 
proportion of the survival activity of the PBS-soluble 
components of E17 rat skeletal muscle may be due to 
FGF-5. 
Members of the FGF family, including FGF-5, have a 
propensity to bind to components of the extracellular 
matrix. We thus attempted to determine whether ad-
ditional, matrix-bound, FGF-5-like motoneuron sur-
vival activity that could not be extracted with PBS 
alone is present in embryonic rat skeletal muscle. The 
pellets obtained after PBS extraction of E17 muscle 
were reextracted with PBS containing 3 M NaCl and 
10 mM EOT A. These conditions would be expected to 
disrupt interactions between the extracellular matrix 
and molecules bound to it and thus allow solubiliza-
tion of matrix-bound components. The high molar salt 
extract of E17 muscle exhibited a maximal survival 
effect on cultured chick spinal motoneurons which 
was less than that observed with the soluble extract 
(approximately 37% survival after 3 days in culture; 
Figure 5, column El. although this effect was achieved 
at lower total protein concentrations (60 I!g/ml). Im-
munoprecipitation of this extract with anti-FGF-5 anti-
serum led to an 83% reduction in the maximal moto-
neuron survival of the extract (Figure 5, column n. 
~ 
> 
~ 
" 
50 
40 
'" 30 
c 
~ 
" ..
c: 
~2 
o 
le 
10 • 
l 1 i , 
o 0001 0 0 I 0 I I 10 100 
FGF-S conc@ntrat.on Ingml-') 
Figure 4. Motoneuron Survival Activity of Increasing Concentra-
tions of Recombinant Human FeF-S Prior to or Following Immu-
noprecipitation with Either Anti-FGF-S or Control Anti-CNTF An-
tiserum 
Closed circles, survival prior to immunoprecipitation; open cir-
cles, survival following immunoprecipitation with anti-FGF-S an-
tibodies; squares, survival following immunoprecipitation with 
anti-CNTF antibodies. 
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Figure 5. Motoneuron Survival Activity of E17 Muscle Extracts 
Column A: Control, no muscle extract. Columns B-D: Addition 
of 250 I1g/ml PBS-s'oluble extract prior to (column B) and follow-
ing immunoprecipitation with anti-FGF-S (column Cl or anti-
CNTF (column D) antiserum. Columns E-G: Addition of 70 I1g/ml 
high molar salt-EDTA extract prior to (column E) and following 
immunoprecipitation with anti-FGF-S (column F) or anti-CNTF 
Icolumn G) antiserum. Results are means from at least four cul-
tures from at least two independent experiments. Error bars rep-
resent 1 SEM. Statistical significance was established with Stu-
dent's t test: • Significantly different from PB S-soluble extract 
prior to immunoprecipitation, P < 0.0005 .•• Significantly differ-
ent from high salt extract prior to immunoprecipitation, P < 
0.00005. 
Thus, approximately 65% of the total (PBS and high 
molar salt) maximal motoneuron survival activity ex-
tractable from E17 rat skeletal muscle can be immuno-
precipitated by anti-FGF-5 antiserum, and approxi-
mately one-half of this activity is apparently quite 
tightly bound to the matrix. Control precipitation of 
either the soluble or matrix-bound extract of embry-
onic muscle with anti-CNTF antiserum did not lead 
to a significant reduction in the motoneuron survival 
activity of either of these extracts (Figure 5, columns 
D and G). Reextraction of the muscle pellets with PBS 
alone failed to solubilize significant amounts of either 
total protein or motoneuron survival activity (data not 
shown). 
Immunoprecipitation of Adult Muscle Extracts with 
Anti-FGF-S Antiserum Suggests That FGF-S Protein 
Is Almost Entirely Matrix Bound 
To determine whether FGF-5 might also be a compo-
nent of adult rat skeletal muscle extracts, attempts 
were made to precipitate motoneuron survival activity 
from adult muscle extracts with anti-FGF-5 antiserum 
linked to protein G-Sepharose. PBS-soluble extracts 
of adult skeletal muscle exhibited maximal motoneu-
ron survival activity of approximately 37% at a protein 
concentration of 125 J-lg/ml after 3 days in culture (Fig-
ure 6, column B). However, unlike the PBS-soluble 
embryonic muscle extract, none of the activity of the 
soluble extract of adult rat skeletal muscle could be 
precipitated with anti-FGF-5 antiserum (Figure 6, col-
umn Cl. Conversely, a major proportion (71 %) of the 
maximal survival activity of the high molar salt extract 
of adult rat skeletal muscle extract (33% at 7 J-lg/ml 
protein) could be precipitated with anti-FGF-S antise-
rum (Figure 6, columns E and F). The fact that FGF-5 
immunoprecipitable activity could not be extracted 
from adult rat skeletal muscle with PBS and required 
harsher extraction conditions of high salt and EDTA 
to facilitate its solubilization, suggests that FGF-5 in 
adult rat muscle is almost exclusively tightly bound to 
the extracellular matrix. Small proportions of both the 
PBS-soluble and high molar salt-EDTA extracts of 
adult muscle (approximately 30% and 29%, respec-
tively) were amenable to immunoprecipitation with 
anti-CNTF antiserum (Figure 6, columns D and G). 
Discussion 
The motoneu ron survival activity obtainable from em-
bryonic and adult rat skeletal muscle could be broadly 
divided into two categories: that readily extractable 
with PBS and that requiring high molar salt and EDTA 
to effect solubilization. Of the four types of muscle 
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Figure 6. Motoneuron Survival Activity of Adult Muscle Extracts 
Column A: Control, no muscle extract. Columns B-D: Addition 
of 125 I1g/ml PBS-soluble extract prior to (column B) and follow-
ing immunoprecipitation with anti-FGF-S (column Cl or anti-
CNTF (column D) antiserum. Columns E-G: Addition of 7 I1g/ml 
high molar salt-EDTA extract prior to (column E) and following 
immunoprecipitation with anti-FGF-S (column F) or anti·CNTF 
(column G) antiserum. Resultsare means from four cultures from 
two experiments. Error bars represent 1 SEM. Statistical signifi. 
cance was established with Student's t test: • Significantly differ-
ent from PBS-soluble extract prior to immunoprecipitation, P < 
0.05 .•• Significantly different from high salt extract prior to im-
munoprecipitation, P < 0.0005 .••• Significantly different from 
high salt extract prior to immunoprecipitation, P < 0.05. 
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extract prepared, the PBS-soluble extract of E17 mus-
cle gave the greatest maximal survival effect on cul-
tured chick motoneurons (60% after 3 days in culture). 
The other embryonic and two adult extracts exhibited 
significantly lower yet similar maximal survival effects 
(approximately 36%), although the maximal effects of 
the soluble and matrix-bound adult extracts may have 
been reduced by the presence of toxic components 
in these extracts. The high maximal survival activity 
extractable from embryonic compared with adult 
skeletal muscle may reflect a greater reliance of devel-
oping embryonic motoneurons on trophic support 
during the period of naturally occurring motoneuron 
death or the production by adult muscle of a "neuro-
trophic cocktail" not optimally suited to the survival 
of embryonic neurons. Interestingly, high salt-EDTA 
extraction of embryonic and adult skeletal muscle af-
forded extracts with apparent specific activities rela-
tive to total protein content that were approximately 
4- and 17-fold greater, respectively, than their PBS-
soluble counterparts. Thus, compared with soluble 
proteins, a larger proportion of matrix-bound pro-
teins in muscle exhibit motoneuron survival activity. 
Immunoprecipitation experiments with a specific 
antiserum to FGF-5 were used to ascertain what per-
centage, if any, of the motoneuron survival activity of 
the embryonic and adult muscle extracts might be 
attributable to FGF-5. From hindlimb skeletal muscle 
prepared from E17 rats, at which age the period of 
naturally occurring embryonic motoneuron death is 
underway (Oppenheim, 1986), approximately 60% of 
the total maximal extractable survival activity could 
be immunoprecipitated by the anti-FGF-5 antiserum. 
The FGF-5 immunoprecipitable activity in E17 muscle 
was distributed between a PBS-soluble form and a 
less readily extracted species, the latter requiring high 
molar salt and EDTA for extraction. In contrast, FGF-5 
activity in adult skeletal muscle was found to exist 
exclusively in the latter, matrix-bound form. FGF-5, 
like the other members of the FGF family, exhibits 
strong binding to the glycosaminoglycan heparin 
(Zhan et al., 1988) and thus would be expected to asso-
ciate tightly to heparan sulphate-like components of 
the extracellular matrix. Thus, the apparent lesser sol-
ubility of the FGF-5 immunoprecipitable activity from 
adult rat skeletal muscle compared with that of the 
embryo probably reflects a difference in the nature or 
composition of the extracellular matrix in the adult 
animal. Similar developmental changes have pre-
viously been noted in the case of extractability of 
other components of the extracellular matrix, such as 
laminin (Kucherer-Ehret et al., 1990). 
An antiserum to a 27 amino acid peptide from CNTF 
(StOckli et al., 1991) was favored over preimmune se-
rum as a control serum for the immunoprecipitation 
experiments. The anti-CNTF antiserum was unable to 
precipitate the motoneuron survival activity of either 
recombinant FGF-5 or embryoniC muscle extracts; the 
latter finding is in concordance with the observations 
that CNTF mRNA in the rat is below detectable limits 
during the period of naturally occurring motoneuron 
death (Stockli et al., 1989, 1991). These results allowed 
us to disregard with confidence the interpretation 
that reductions in motoneuron survival activity ob-
served following precipitation with the anti-FGF-5 an-
tiserum might be due to nonspecific binding of a 
neurotrophic factor(s) to the generally increased 
IgG levels expected in immunized animals. A small 
yet significant reduction in the survival activity of 
adult muscle extracts could be brought about by im-
munoprecipitation with the anti-CNTF antiserum. 
This phenomenon is probably the result of the pres-
ence of CNTF in nerves innervating adult muscle. In-
deed, CNTF immunoreactivity is clearly detectable in 
Schwann cells surrounding nerves in sections of adult 
skeletal muscle (B. Holtmann and M. Sendtner, un-
published data). Furthermore, extracts of adult rat 
skeletal muscle that has been surgically denervated 
for 7 days, during which time nerve fibers and their 
accompanying Schwann cells distal to the lesion site 
would be expected to degenerate, no longer exhibit 
anti-CNTF immunoprecipitable motoneuron survival 
activity (R. A. Hughes and M. Sendtner, unpublished 
data). 
FGF-5 immunoprecipitable activity in E17 skeletal 
muscle extracts could originate from two sources, the 
muscle itself (as the observed expression of FGF-5 
mRNA in this tissue would attest) and/or a site of ear-
lier expression. Indeed, the most prominent embry-
onic expression of FGF-5 mRNA beyond gastrulation 
in the mouse occurs at E12.5-E14.5 in a patch of mesen-
chyme at the base of the hindlimb (Haub and Gold-
farb, 1991). It may be that FGF-5 protein similarly ex-
pressed in the developing rat is deposited in the 
surrounding muscle and thus contributes to the ob-
served FGF-5-like activity in E17 muscle extracts. The 
expression of FGF-5 mRNA in adult rat muscle is con-
sistent with the hypotheSiS that the major source of 
FGF-5 in this tissue is the muscle itself. The previously 
reported absence of FGF-5 mRNA in Northern blots of 
RNA from adult mouse skeletal muscle (Haub et al., 
1990) suggests either that the FGF-5 gene is regulated 
differently in these two species, or that the amounts 
of FGF-5 mRNA in mouse were below detectable lim-
its. Our investigations do not formally exclude the 
possibility that the FGF-5-like activity observed in skel-
etal muscle might be supplied in part by nerve fibers 
present within the muscle. However, the apparent 
contribution of CNTF to the survival activity of adult 
muscle extracts is small, indicating that the contami-
nation of these extracts with nerve fibers is minor. 
Thus, unless sciatic nerve proves to be an exception-
ally rich source of FGF-5, it is unlikely that the FGF-5-
like activity observed !n muscle extracts is derived to 
a significant extent from nervous tissue. 
A family of membrane-spanning protein tyrosine ki-
nases, encoded by at least four distinct genes, are 
capable of acting as signal-transducing units for the 
FGFs (Ruta et al., 1988; Kornbluth et al., 1988; Lee et 
al., 1989; Dionne et al., 1990; Pasquale, 1990; Miki et 
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al., 1991; Keegan et al., 1991; Partanen et al., 1991; Stark 
et al., 1991). These tyrosine kinases exist in a variety 
of molecular forms generated by alternative RNA 
splicing Oohnson et al., 1990, 1991) and bind different 
members of the FGF family with differing affinities 
(Johnson et al., 1991; Miki et al., 1991; Partanen et al., 
1991). The binding of FGFs to the receptor tyrosine 
kinases requires the participation of heparan sulphate 
proteoglycan or soluble heparin (for review, see Klags-
brun and Baird, 1991). Recombinant human FGF-5 is 
able to bind and activate FGF receptors 1 and 2. The 
relative affinities of FGF-5 and bFGF for these recep-
tors (D. Clements, J.-K. Wang, C. Dionne, and M. Gold-
farb, unpublished data) correlate with the relative 
concentrations of these factors required to support 
chick motoneurons in culture. This would suggest 
that the expression of FGF receptor 1 or 2 in embry-
onic motoneurons partially accounts for FGF survival 
effects. Indeed, mRNA for FGF receptor 1 has been 
detected in motolleurons of newborn and adult rats 
using in situ hybridization techniques (Wanaka et al., 
1990,1991). Given the enhanced survival of chick mo-
toneurons cultured in the presence of a combination 
FGF-5 and bFGF, it is possible that at least three dis-
tinct FGF receptors mediate survival of chick moto-
neurons in vitro: one receptor with specificity for 
FGF-5, one for bFGF, and a third (perhaps FGF receptor 
1 or 2) able to respond to both ligands. 
The molecular nature of the motoneuron survival 
activity present in embryonic and adult skeletal mus-
cle extracts that could not be immunoprecipitated by 
anti-FGF-5 antiserum remains undetermined. The pres-
ence of other FGF-related molecules in skeletal mus-
cle of several species is relatively well documented, 
even though the exact molecular entity under ques-
tion has not always been precisely defined. Using im-
munohistochemical techniques, bFGF-like immuno-
reactivity has been detected in developing skeletal 
muscle of embryonic chick (Joseph-Silverstein et al., 
1989), rat (Gonzalez et al., 1990), and rabbit (Morrow 
et al., 1990), and a molecule with bFGF-like characteris-
tics has been detected in human embryonic and adult 
skeletal muscle (Vaca et al., 1989). In a similar manner, 
polyclonal antisera to aFGF have been used to demon-
strate the presence of this molecule in embryonic rat 
skeletal muscle (Fu et al., 1991), and mRNA for aFGF 
has been detected by Northern blot analysis of total 
RNA obtained from embryonic cattle muscle (Alterio 
et al., 1990). Nonetheless, the absence of demonstra-
ble secretion of aFGF and bFGF makes it difficult to 
reconcile how either of these factors might be made 
available to act as a target-derived neurotrophic factor 
for motoneu rons. 
A number of other candidate target-derived trophic 
factors for developing spinal motoneurons have pre-
viously been proposed. One of these, choline acetyl-
transferase development factor (CDF), has been puri-
fied from rat skeletal muscle and shown to increase 
levels of choline acetyltransferase activity in embry-
onic rat spinal cord cultures (McManaman et al., 1988, 
1989). Although conclusive survival effects of CDF on 
highly enriched or purified motoneuron cultures 
have yet to be demonstrated, CDF does share a num-
ber of properties with FGF-5, including apparent 
abundance in skeletal muscle and effects that are ad-
ditive with bFGF (McManaman et al., 1989; McMana-
man and Crawford, 1991). Nonetheless, several differ-
ences between CDF and FGF-5, such as extent of 
glycosylation and heparin binding characteristics, 
suggest that they are distinct entities. Identification 
,of the exact molecular nature of CDF awaits the clon-
ing of this factor. 
A cholinergiC differentiation factor for sympathetic 
neurons originally isolated from heart muscle-condi-
tioned medium (Fukada, 1985) was found upon clon-
ing (Yamamori et al., 1989) to be identical to leukemia 
inhibitory factor (LlF). LlF exhibits a degree of func-
tional overlap with CNTF (for review, see Patterson, 
1992), including a survival effect on cultured rat moto-
neurons (Martinou et al., 1992). It has recently been 
reported that LlF mRNA, unlike CNTF message, is 
present in low amounts in embryonic rat skeletal mus-
cle (Patterson and Fann, 1992). However, it has been 
shown that murine LlF is unable to act on other chick 
cells in culture even at high concentrations (Rohrer, 
1992). presumably as a result of species differences. 
Thus, LlF would not be expected to contribute to the 
motoneu ron survival activity of the rat muscle extracts 
observed in the cultures described here. The extent 
to which LlF produced in rat skeletal muscle might 
promote motoneuron survival and function remains 
a matter of conjecture. 
The data presented here demonstrate that FGF-S is 
a major skeletal muscle-derived survival factor for cul-
tured spinal motoneurons. Furthermore, the expres-
sion of FGF-S in muscle and its secretory nature are 
compatible with the hypothesis that this protein may 
provide target-derived trophic support to motoneu-
rons both during embryonic development and in 
adulthood. Other experimental systems could be 
used to clarify whether FGF-S indeed plays a role in 
regulating motoneuron survival in vivo, or perhaps 
partakes in the modulation of other motoneuron-
related functions, such as transmitter synthesis or syn-
apse formation. These systems include the in vivo ad-
ministration of blocking FGF-S antibodies during de-
velopment, and the gene knockout or tissue-specific 
overexpression of FGF-5 in transgenic animals. 
Experimental Procedures 
Materials . 
Recombinant human FGF·5 was purified from the soluble frac-
tion of Escherichiacoli Iysates by heparin-Sepharose chromatog-
raphy and Mono S fast protein liquid chromatography (D. elem-
ents, ).-K. Wang, C. Dionne, and M. Goldfarb, submitted). 
Recombinant rat CNTF was prepared from transfected E. coli 
using a modification of the method described by Masiakowski 
et al. (1991), in which the chromatographic purification of the 
protein on DEAE-cellulose was replaced by a single reverse-
phase, high pressure liquid chromatography step on a semiprep-
arative, butyl column (Baker). Recombinant human K-FGF was 
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generously provided by C Basilico, NY_ Recombinant aFGF and 
bFGF were kind gifts from W. Risau, Martinsried, Germany. 
N-fluorenylmethoxycarbonyl (Fmoc) amino acid derivatives, 
2-(1 H-benzotriazol-l-yll-l,l,3,3-tetramethylu ron ium hexafl uoro-
phospate (HBTU), HMP resin, solvents, and miscellaneous re-
agents for peptide synthesis were from Applied Biosystems, 
Weiterstadt, Germany; Freund's complete and incomplete adju-
vants and leibovitz's l-15 medium, from GIBCO BRl, Eggenstein, 
Germany; metrizamide, from Serva, Heidelberg, Germany; pro-
tein G-Sepharose solution, from Pharmacia, Freiburg, Germany; 
general laboratory reagents, from Sigma Chemie, Deisenhofen, 
Germany, and E. Merck, Darmstadt, Germany. 
Northern Blots 
Hindlimb skeletal muscle was dissected from embryonic (E15 
and El7), newborn, and adult rats killed by ether overdose. Partic-
ular care was taken to exclude bone, cartilage, a nd skin, and total 
RNA was extracted from the muscle according to the method 01 
Chomczynski and Sacchi (1987). RNA samples thus obtained 
were glyoxylated, electrophoresed through a 1.4% agarose gel 
(lindholm et aI., 1988), and vacuum blotted to nylon membranes 
(Hybond-N, Amersham, Braunschweig, Germany). The mem-
branes were hybridized overnight in 50% formamide as de-
scribed (Castren et aI., 1992) with a 500 bp cRNA probe to FGF-S. 
The probe (specific activity 10" cpm/Ilg) wa~ made by run-on 
transcription of a pBluescript SK+ vector containing a 2.2 kb 
mouse Fgf-S cDNA fragment (Haub and Goldfarb, 1991) linear· 
ized with BglIl. 
Antiserum Preparation 
The nonadecapeptide CFKQSEQPElSF1V1VPEK containing a rel-
atively hydroph ilic 18 amino acid sequence from near the C-ter-
minus of human FGF-5 (Phe-217 to lys-234), which is highly con-
served between species (human-mouse amino acid identity at 
100%; Haub et aI., 1990) but bears no sequence homology With 
other members of the FGF family, was synthesized on an Applied 
Biosystems 431A automated peptide synthesizer using N-Fmoc 
amino acid derivatives and HBTU-assisted coupling steps. Fol-
lowing deprotection and cleavage from the resin, the crude pep-
tide free acid was purified as required by reverse-phase, high 
pressure liquid chromatography from 0.1% trifluoroacetic acid 
on a butyl column using an acetonitrile gradient (0%-70% aceto-
nitrile in 30 min). New Zealand rabbits were immunized by intra-
cutaneous injection into at least four sites on the back with 700 
Ilg of the above-described peptide dissolved in 500 III of H 20 and 
emulsified with an equal volume of Freund's complete adjuvant. 
Rabbits were boosted with a similar quantity of peptide solution 
emulsified with Freund's incomplete adjuvant at 3-4 weekly in-
tervals. Blood samples were removed 1 week after boosting by 
severing an ear vein, allowed to coagulate (37°C for 2 hr then 
overnight at 4°C), and centrifuged (6000 x g, 25 min). The resul-
tant serum was sterile filtered (0.2 Ilm) and used in immunopre-
cipitation assays. 
Motoneuron Cultures 
Chick spinal motoneuron cultures were prepared as previously 
described (Arakawa et aI., 1990)_ Briefly, lateral motor columns 
were dissected from the lumbar region of six E6 chick spinal 
cords, trypsinized, and triturated. The resultant cell suspension 
was filtered and centrifuged through a bed of6.8% metrizamide. 
Cells from the interface were collected, and the suspension was 
concentrated by centrifugation, resuspended in CO,-buffered 
l-15 medium supplemented with horse serum (10%), and plated 
in four well culture dishes (C A. Greiner und Sohne GmbH, 
Nurtingen, Germany) at a concentration of 1000-2000 cells per 
well. The wells had been previously coated with poly-m-
ornithine and laminin (the latter solu.;.)n was removed just prior 
to plating). The cells were incubated at 37°C in a humidified 
incubator in an atmosphere of 5% CO, for 1 hr, factors and/or 
extracts were added at the appropriate concent rations, and cells 
were returned to the incubator for the length of the experiment. 
The culture medium and factors were renewed after 24 hr. large 
(~14 Ilm in diameter), phase-bright cells were counted 72 hr 
after plating, unless otherwise specified, in predetermined areas 
corresponding to 23% of each well bottom. 
Preparation of Skeletal Muscle Extracts 
Hindlimb skeletal muscle was dissected from embryonic (El7) 
and adult rats as described above. Extracts of soluble skeletal 
muscle proteins were obtained by homogenizing the muscle 
on ice in 2-3 volumes of PBS in a glass-glass homogenizer and 
centrifuging (100,000 x g, 4°C, 30 min). Matrix-bound compo-
nents were obtained by reextraction of the pellets obtained 
abol/e with 2-3 initial muscle volumes of PBS supplemented with 
NaCI (3 M) and EDTA (10 mM) and centrifugation as for soluble 
extracts. The protein concentration of the resultant extracts was 
determined by the method of Bradford (1976) using bovine se-
rum albumin as a standard. The skeletal muscle extracts were 
stored at -70°C until use. 
Immunopredpitation Experiments 
Thirty microliters of protein G-Sepharose Fast Flow suspension 
was centrifuged (14,000 rpm,S mini, and the Sepharose was re-
suspended in 150 ~I of 0.5 x Tris-butfered saline (pH 7.4). To 
this suspension was added 200 ~I of either anti-FGF-5 peptide 
antiserum prepared as described above or control antiserum 
raised against a 27 amino acid peptide from CNTF (antiserum I; 
Stockli et aI., 1991). The mixture was incubated for 1 hr at room 
temperature on an inverting mixer. The protein G-Sepharose 
antiserum complex was washed three times with 500 III of Tris-
buffered saline, after which 20 ~I of 0.5 x TBS and either 60 ~I of 
muscle extract (5 Ilg/~i) or 60 ~I of recombinant human FGF-5 
solution 11 ng/~1 in L-15(CO,)) medium supplemented with 10% 
horse serum) were added. Following centrifugation. the resul-
tant supernatants were added to motoneuron cultures. 
Acknowledgments 
We wish to thank len-Kuei Wang for the purification 01 recombi-
nant FGF-S and Or. Oavid Edgar lor suggesting the use of EOTA 
to assist in the extraction of matrix-bound proteins. R. A. H. was 
the recipient of a postdoctoral fellowship from the Alexander 
von Humboldt-Stiftung. 
The costs of publication of this article were defrayed in part 
by the payment of page charges. This article must there lore be 
hereby marked "advertisement' in accordance with 18 USC Sec-
tion 1734 solely to indicate this fact. 
Received August 21. 1992; revised December 15, 1992. 
References 
Abraham, I. A., Mergia, A., Whang,l. L., Tumolo. A., Friedman, 
I., Hjerrild. K. A., Gospodarowicz, D., and Fiddes, I. C. (1986). 
Nucleotide sequence of a bovine clone encoding the angiogenic 
protein, basic libroblast growth factor. Science 233, 545-548. 
Alterio, I .. Courtois. Y., Robelin, I., Bechet, D., and Martelly, I. 
(1990). Acidic and basic fibroblast growth factor mRNAs are ex-
pressed by skeletal muscle satellite cells. Biochem. Biophys. Res. 
Commun. 166. 1205-1212. 
Arakawa, Y., Sendtner, M., and Thoenen, H. (1990). Survival effect 
of ciliary neurotrophic factor (CNTf) on chick embryonic moto-
neurons in culture: comparison with other neurotrophiC factors 
and cytokines. I. Neurosci. 70, 3507-3515. 
Barde, Y.-A. (1989). Trophic factors and neuronal survival. Neu-
ron 2, 1525-1534. 
Bates, B., Hardin, L Zhan, X., Orickamer, K., and Goldfarb, M. 
(1991). Biosynthesis of human fibro'llast growth factor-5. Mol. 
Cell. BioI. 11, 1840-1845. 
Bennett, M. R., Lai, K., and Nurcombe, V. (1980). Identification of 
embryonic motoneurons in vitro: their survival is dependent on 
skeletal muscle. Brain Res. 19(), 537-542. 
Bloch-Gallego, E., Huchet, M., El M'hamdi, H., Xie, F.-K., Tanaka, 
H., and Henderson, C. E. (1991). Survival in vitro of motoneurons 
Neuron 
376 
identified or purified by novel antibody-based methods is selec-
tively enhanced by muscle-derived factors. Development 111, 
221-232. 
Bradford, M. M. (1976). A rapid and sensitive method for the 
quantitation of microgram quantities of protein utilizing the 
principle of protein.<fye binding. Anal. Biochem. 72,248-254. 
Calof, A.lo, and Reichardt,lo F. (1984). Motoneurons purified by 
cell sorting respond to two distinct activities in myotube-
conditioned medium. Dev. BioI. 106, 194-210. 
Castren, E., Zafra, F., Thoenen, H., and lindholm, D. (1992). light 
regulates the expression of brain.<ferived neurotrophic factor 
mRNA in rat visual cortex. Proc. Natl. Acad. Sci. USA, in press. 
Chomczynski, P., and Sacchi, N. (1987). Single-step method of 
RNA isolation by guanidinium thiocyanate-phenol-chloroform 
extraction. Anal. Biochem. 162, 156-159. 
Dionne, CA., Crumley, G., Bellot, F., Kaplow, J. M., Searfoss, G., 
Ruta, M., Burgess, W. H., Jaye, M., and Schlessinger, J. (1990), 
Cloning and expression of two distinct high-affinity receptors 
cross-reacting with acidic and basic fibroblast growth factors. 
EMBO J. 9, 2685-2692. 
Dohrmann, U., Edgar, D., Sendtner, M., and Thoenen, H. (1986). 
Muscle-derived factors that support survival and promote fiber 
outgrowth from embryonic chick spinal motor neurons in cul-
ture. Dev. BioI. 118,209-221. 
Flanigan, T. P., Dicl(son, J. G., and Walsh, F. S. (1985). Cell survival 
characteristics and choline acetyltransferase activity in motor 
neurone-enriched cultures from chick embryo spinal cord. j. 
Neurochem.45, 1323-1326. 
Fu, Y.-M., Spirito, P., Yu, Z.-X., Biro, S., Sasse, J., Lei, I., Ferrans, 
V. J., Epstein, S. E., and Casscells, W. (1991). Acidic fibroblast 
growth factor in the developing rat embryo. I. Cell BioI. 114, 
1261-1273. 
Fukada, K. (1985). Purification and partial characterization of a 
cholinergic neuronal dilterentiation factor. Proc. Natl. Acad. Sci. 
USA 82, 8795-8799. 
Gonzalez, A.-M., Buscaglia, M., Ong, M., and Baird, A. (1990). 
Distribution of basic fibroblast growth factor in the 18.<fay rat 
fetus: localization in the basement membranes of diverse tis-
sues. J. Cell BioI. 110, 753-765. 
Hamburger, V. (1958). Regression versus peripheral control of 
differentiation in motor hyperplasia. Am. ). Anat. 102,365-410. 
Haub, 0., and Goldfarb, M. (1991). Expression of the fibroblast 
growth factor-5 gene in the mouse embryo. Development 112, 
397-406. 
Haub, 0., Drucker, B., and Goldfarb, M. (1990). Expression of 
the murine fib rob last growth factor 5 gene in the adult central 
nervous system. Proc. Natl. Acad. Sci. USA 87, 8022-8026. 
Hebert, J. M., Basilico, c., Goldfarb, M., Haub, 0., and Martin, 
G. R. (1990). Isolation of cDNAs encoding four mouse FGF family 
members and characterization of their expression patterns dur-
ing embryogenesis. Dev. BioI. 138, 454-463. 
Hebert, J. M., Boyle, M., and Martin, G. R. (1991). mRNA localiza-
tion studies suggest that murine FGF-5 plays a role in gastrula-
tion. Development 112, 407-415. 
Hollyday, M., and Hamburger, V. (1976). Reduction of the natu-
rally occurring motor neuron loss by enlargement of the periph-
ery. J. Comp. Neurol. 170, 311-320. . 
Hopp, T. P., and Woods, K. R. (1981). Prediction of protein anti-
genic determinants from amino acid sequences. Proc. Natl. 
Acad. Sci. USA 78, 3824-3828. 
Joong, S. J., Oh, T. H., and Markelonis, G. J. (1991). A neurite-
promoting factor from muscle supports the survival of cultured 
chicken spinal motor neurons. J. Neurobiol. 22, 462-474. 
lohnson, D. E., lee, P.l.,lu, I., and Williams, lo T. (1990). Diverse 
forms of a receptor for acidic and basic fibroblast growth factors. 
Mol. Cell. BioI. 10, 4728-4736. 
lohnson, D. E., lu, I., Ch en, J., Werner, S., and Williams, lo T. 
(1991). The human fibroblast growth factor receptor genes: a 
common structural arrangement underlies the mechanisms for 
generating receptor forms that differ in their third immunoglob· 
ulin domains. Mol. Cell. BioI. 11,4627-4634. 
Joseph·Silverstein, J., Consigli, S. A., Lyser, K. M., and Ver Pault, 
C (1989). Basic fibroblast growth factor in the chick embryo: 
immunolocalization to striated muscle cells and their precur-
sors. I. Cell BioI. 108, 2459-2466. 
Kaufman, lo M., Barry, S. R., and Barrett, J. N. (1985). Characteriza-
tion of tissue.<ferived macromolecules affecting transmitter syn· 
thesis in rat spinal cord neurons. J. Neurosci. 5, 160-166. 
Keegan, K., lohnson, D. E., Williams, lo T., and Hayman, M. J. 
(1991). Isolation of an additional member of the fibroblast growth 
factor receptor family, FGFR-3. Proc. Nat!. Acad. Sci. USA 88, 
1095-1099. -
Klagsbrun, M., and Baird, A. (1991). A dual receptor system is 
required for basIC fibroblast growth factor activity. Cell 67, 229-
231. 
Kornbluth, 5., Paulson, K. E., and Hanafusa, H. (1988). Novel tyro-
sine kinase identified by phosphotyrosine antibody screening of 
cDNA libraries. Mol. Cell. BioI. 8, 5541-5544. 
Kucherer·Ehret, A., Pottgiesser, J., Kreutzberg, G. W., Thoenen, 
H., and Edgar, D. (1990). Developmental loss of laminin from the 
interstitial extracellular matrix correlates with decreased laminin 
gene expression. Development 110, 1285-1293. 
Kyle, j., and Doolittle, R. F. (1982). A simple method fordisplaying 
the hydropathic character of a protein. J. Mol. BioI. 157,105-132. 
Lee, P. L.,lohnson, D. E., Cousens, L. S., Fried, V.A.,and Williams, 
L. T. (1989). Purification and complementary DNA cloning of a 
receptor for basic fibroblast growth factor. Science 245, 57-60. 
Lin, L.·F. H., Mismer, D., Lile, J. D., Armes, L. G., Butler, E. T.,III. 
Vannice, J. L., and Collins, F. (1989). Purification, cloning, and 
expression of ciliary neurotrophic factor (CNTF). Science 246, 
1023-1025. 
lindholm, D., Heumann, R., Hengerer, B., and Thoenen, H. 
(1988). Interleukin 1 increases stability and transcription of 
mRNA encoding nerve growth factor in cultured rat fibroblasts. 
J. BioI. Chem. 263, 16348-16351. 
Martinou, J. C, Le Van Thai, A., Cassar, G., Roubinet, F., and 
Weber, M. J. (1989). Characterization of two factors enhancing 
choline acetyltransferase activity in cultures of purified rat moto· 
neurons. I. Neurosci. 9, 3645-3656. 
Martinou, J .. c., Martinou, I., and Kato, A. C (1992). Cholinergic 
differentiation factor (CDF/UF) promotes survival of isolated rat 
embryonic motoneurons in vitro. Neuron 8, 737-744. 
Masiakowski, P., Liu, H., Radziejewski, C, Lottspeich, F., Ober-
thuer, W., Wong, V., Lindsay, R. M., Furth, M. E., and Panayo-
tatos, N. (1991). Recombinant human and rat ciliary neurotrophic 
factors. J. Neurochem. 57, 1003-1012. 
McManaman, J. L., and Crawford, F. G. (1991). Skeletal muscle 
proteins stimulate cholinergic differentiation of human neuro-
blastoma cells. J. Neurochem. 57, 258-266. 
McManaman, J., Crawford, F., Clark, R., Richker, J., and Fuller, 
F. (1989). Multiple neurotrophic factors from skeletal muscle: 
demonstration of effects of basic fibroblast growth factor and 
comparisons with the 22-kilodalton choline acetyltransferase de-
velopment factor. J. Neurochem. 53, 1763-1771. 
McManaman, J. lo, Crawford, F. G., Stewart, S. S., and Appel, 
S. H. (1988). Purification of a skeletal muscle polypeptide which 
stimulates choline acetyltransferase activity in cultured spinal 
cord neurons. J. BioI. Chem. 263, 5890-5897. 
Miki, T., Fleming, T. P., Bottaro, D. P., Rubin, I. S., Ron, D., and 
Aaronson, S. A. (1991). ExpresSion cDNA cloning of the KGF re-
ceptor by creation of a transforming autocrine loop. Science 251, 
72-75. 
Morrow, N. G., Kraus, W. E., Moore, I. W., Williams, R. S., and 
Swain, I. l. (1990). Increased expression of fibroblast growth fac-
tors in a rabbit skeletal muscle model of exercise conditioning. 
I. Clin. Invest. 85, 1816-1820. 
FGF-5 and Motoneuron Survival 
3n 
O'Brien, R. J., and Fischbach, G. D. (1986). Isolation of embryonic 
chick motoneurons and their survival in vitro. J. Neurosci. 6, 
3265-3274. 
Oppenheim, R. W. (1986). The absence of significant postnatal 
motoneuron death in the brachial and lumbar spinal cord of the 
rat_ J. Comp. Neurol. 246, 281-286. 
Oppenheim, R. W. (1991). Cell death during development of the 
nervous system. Annu. Rev. Neurosci. 14, 453-501. 
Oppenheim, R. W., Prevette, D., Qin-Wei, Y., Collins, F., and 
MacDonald, J. (1991). Control of embryonic motoneuron survival 
in vivo by ciliary neurotrophic factor. Science 251,1616-1618. 
Partanen, J., Miikelaii, T. P., Eerola, E., Korhonen, J., Hirvonen, 
H., Claesson-Welsh, l., and Alitalo, K. (1991). FGFR-4, a novel 
acidic fibroblast growth factor receptor with a distinct expres-
sion pattern. EMBO J. 10, 1347-1354. 
Pasquale, E. B. (1990). A distinctive family of embryonic protein-
tyrosine kinase receptors. Proc. Natl. Acad. Sci. USA 87, 5812-
5816. 
Patterson, P. H. (1992). The emerging neuropoietic cytokine fam-
ily: first CDFllIF, CNTF and Il-6; next ONC, MGF, GCSF? Curr. 
Opin. Neurobiol. 2, 94-97. 
Patterson, P. H., and Fann, M.-J. (1992). Further studies of the 
distribution of CDFllIF mRNA. Ciba Found. Symp. 167, 125-135. 
Rohrer, H. (1992). Cholinergic neuronal differentiation factors: 
evidence for the presence of both CNTF-like and non-CNTF-like 
factors in developing rat footpad. Development 114, 689-698. 
Ruta, R., Howk, R., Ricca, G., Drohan, W., Zabelshansky, M., 
laureys, G., Barton, D. E., Francke, U., Schlessinger, J., and Givol, 
D. (1988). A novel protein tyrosine kinase gene whose expression 
is modulated during endothelial cell differentiation. Oncogene 
3,9-15. 
Schnaar, R. L., and Schaffner, A. E. (1981). Separation of cell types 
from embryonic chicken and rat spinal cord: characterization of 
motoneuron-enriched fractions. J. Neurosci. 1,204-217. 
Sendtner, M., Kreutzberg, G. W., and Thoenen, H. (1990). Ciliary 
neurotrophic factor prevents the degeneration of motor neurons 
after axotomy. Nature 345, 440-441. 
Smith, R. G., McManaman, J., and Appel, S. H. (1985). Trophic 
effects of skeletal muscle extracts on ventral spinal cord neu rons 
in vitro: separation of a protein with morphologic activity from 
proteins with cholinergic activity. J. Cell BioI. 101,1608-1621. 
Stark, K. L., McMahon, J. A., and McMahon, A. P. (1991). FGFR-4, 
anew member of the fibroblast growth factor receptor family, 
expressed in the definitive endoderm and skeletal muscle lin-
eages of the mouse. Development 113, 641-651. 
Stackli, K. A., lottspeich, F., Sendtner, M., Masiakowski, P., Car-
roll, P., Gatz, R., Lindholm, D., and Thoenen, H. (1989). Molecular 
cloning, expression and regional distribution of rat ciliary neuro-
trophic factor. Nature 342,920-923. 
Stockli, K. A., Lillien, L. E., Naher-Noe, M., Breitfeld, G., Hughes, 
R. A., Raff, M. c., Thoenen, H., and Sendtner, M. (1991). Regional 
distribution, developmental changes, and cellular localization of 
CNTF-mRNA and protein in the rat brain. I. Cell BioI. 115,447-
459. 
Vaca, K., Stewart, S. S., and Appel, S. H. (1989). Identification of 
basic fibroblast growth factor as a cholinergic growth factor from 
human muscle. J. Neurosci. Res. 23, 55-63. 
Wanaka, A., lohnson, E. M., Jr., and Milbrandt, J. (1990). localiza-
tion of FGF receptor mRNA in the adult rat central nervous sys-
tem by in situ hybridization. Neuron 5, 267-281. 
Wanaka, A., Milbrandt, J., and Johnson, E. M., Jr. (1991). Expres-
sion of FGF receptor gene in rat development. Development 111, 
455-468. 
Werner, S., Roth, W. K., Bates, B., Goldfarb, M., and Hofschneider, 
P. H. (1991). Fibroblast growth factor 5 proto-oncogene is ex-
pressed in normal human fibroblasts and induced by serum 
growth factors. Oncogene 6, 2137-2144. 
Yamamori, T., Fukada, K., Aebersold, R., Korsching, S., Fann, 
M.-I., and Patterson, P. H. (1989). The cholinergic neuronal differ-
entiation factor from heart cells is identical to leukemia inhibi-
tory factor. Science 246, 1412-1416. 
Zhan, X., Culpepper, A., Reddy, M., loveless, /., and Goldfarb, 
M. (1987). Human oncogenes detected by a defined medium 
culture assay. Oncogene 1,369-376. 
Zhan, X., Bates, B., Hu, X., and Goldfarb, M. (1988). The human 
FGF-5 oncogene encodes a novel protein related to fibroblast 
growth factors. Mol. Cell. BioI. 8, 3487-3495. 
